[1]
2026. Development and Validation of a Stability-Indicating RP-HPLC Method for Gilteritinib Using a Quality by Design: Research Article. Journal of Pharma Insights and Research. 4, 3 (Jun. 2026), 313–325. DOI:https://doi.org/10.69613/76qgjh07.